...
首页> 外文期刊>Journal of Infectious Diseases >Comparative Metagenomic Study of Alterations to the Intestinal Microbiota and Risk of Nosocomial Clostridum difficile-Associated Disease
【24h】

Comparative Metagenomic Study of Alterations to the Intestinal Microbiota and Risk of Nosocomial Clostridum difficile-Associated Disease

机译:肠道菌群变化和院内艰难梭菌相关疾病风险的比较元基因组学研究

获取原文

摘要

This study investigated the relationship between hospital exposures, intestinal microbiota, and subsequent risk of Clostridium difficile-associated disease (CDAD), with use of a nested case-control design. The study included 599 patients, hospitalized from September 2006 through May 2007 in Montreal, Quebec, from whom fecal samples were obtained within 72 h after admission; 25 developed CDAD, and 50 matched controls were selected for analysis. Nonsteroidal anti-inflammatory drugs and antibiotic use were associated with CDAD. Fecal specimens were evaluated by 16S ribosomal RNA microarray to characterize bacteria in the intestinal microbiota during the at-risk period. Probe intensities were higher for Firmicutes, Proteobacteria, and Actinobacteria in the patients with CDAD, compared with controls, whereas probe intensities for Bacteroidetes were lower. After epidemiologic factors were controlled for, only Bacteroidetes and Firmicutes remained significantly and independently associated with development of CDAD. Hospital exposures were associated with changes in the intestinal microbiota and risk of CDAD, and these changes were not driven exclusively by antimicrobial use.
机译:这项研究使用巢式病例对照设计调查了医院暴露,肠道菌群与艰难梭菌相关疾病(CDAD)后续风险之间的关系。该研究包括599名患者,他们于2006年9月至2007年5月在魁北克蒙特利尔住院,其入院后72小时内获得了粪便样本。选择25个已开发的CDAD,并选择50个匹配的对照进行分析。非甾体类抗炎药和抗生素的使用与CDAD相关。粪便标本通过16S核糖体RNA微阵列进行评估,以表征高危时期肠道菌群中的细菌。与对照组相比,CDAD患者的硬毛,变形杆菌和放线菌的探针强度更高,而拟杆菌的探针强度则较低。在控制了流行病学因素后,仅拟杆菌和硬膜螨仍显着且独立于CDAD的发展。医院暴露与肠道菌群的变化和CDAD的风险有关,而这些变化并非仅由抗菌药物的使用引起。

著录项

  • 来源
    《Journal of Infectious Diseases》 |2010年第12期|p.1877-1884|共8页
  • 作者单位

    Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada|The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada;

    Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada|Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Quebec, Canada;

    The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada;

    Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada;

    The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada;

    National Research Council Canada, Biotechnology Research Institute, Montreal, Quebec, Canada;

    The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada;

  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号